Showing results (1961-1970 of 2,118) with videos related to
Sort By:
Pageof 212
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2018
CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti-PD-1 TreatmentJarem Edwards, James S Wilmott, Jason Madore, et al.JPEN. Journal of Parenteral and Enteral Nutrition|December 11, 2020
Safety Findings in Pediatric Patients During Long-Term Treatment With Teduglutide for Short-Bowel Syndrome-Associated Intestinal Failure: Pooled Analysis of 4 Clinical StudiesSusan Hill, Beth A Carter, Valeria Cohran, et al.Journal of Medicinal Chemistry|August 6, 2019
Profile of a Highly Selective Quaternized Pyrrolidine Betaine αvβ6 Integrin Inhibitor-(3S)-3-(3-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)-4-((1S and 1R,3R)-1-methyl-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-ium-1-yl)butanoate Synthesized by Stereoselective MethylationTim N Barrett, Jonathan A Taylor, Daniel Barker, et al.Ebiomedicine|July 10, 2022
Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithmsThazin Nwe Aung, Saba Shafi, James S Wilmott, et al.Journal for Immunotherapy of Cancer|June 10, 2022
Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapyGrace Heloise Attrill, Carina N Owen, Tasnia Ahmed, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2015
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinomaI D Davis, A Long, S Yip, et al.Nature Communications|April 22, 2020
Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibitionJenny H Lee, Elena Shklovskaya, Su Yin Lim, et al.Ebiomedicine|August 20, 2015
The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression AnalysisMitchell S Stark, Kerenaftali Klein, Benjamin Weide, et al.BMJ Open|March 1, 2020
Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: protocol paper for a mixed methods studyFrances Rapport, Andrea L Smith, Anne E Cust, et al.The British Journal of Dermatology|September 15, 2019
A risk prediction model for the development of subsequent primary melanoma in a population-based cohortA E Cust, C Badcock, J Smith, et al.Pageof 212